arrow
D

Desmond Chee

Oxford University Hospitals NHS Foundation Trust
H指数:13
被引数:932

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
2022-08-2913
OAAI
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

在接受英夫利昔单抗和维多珠单抗治疗的炎症性肠病患者中,两次SARS-CoV-2疫苗剂量后抗体衰减,T细胞免疫和突破性感染

2022-03-1660
OAAI
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients

阿达木单抗和英夫利昔单抗损害SARS-CoV-2抗体反应: 来自11名422生物治疗患者的治疗药物监测研究结果

2021-09-0243
OAAI
Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab
2021-05-270
OA